XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 96,280 $ 59,820
Short-term investments 131,441 268,312
Accounts receivable 17,243 0
Prepaid expenses and other current assets 8,582 6,511
Total current assets 253,546 334,643
Right-of-use asset 4,254 5,114
Other assets 14,066 2,606
Total assets 271,866 342,363
Current liabilities:    
Accounts payable 1,137 4,320
Accrued expenses 16,481 13,427
Operating lease liabilities, current 1,404 1,384
Deferred revenue, current 4,495  
Total current liabilities 23,517 19,131
Operating lease liabilities, net of current portion 3,055 3,969
Deferred revenue, net of current portion 12,041  
Total liabilities 38,613 23,100
Commitments (Note 7)
Stockholders' equity:    
Common stock, $0.001 par value per share, 150,000,000 shares authorized; 56,434,894 and 56,434,219 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 57 57
Additional paid-in capital 911,014 898,513
Accumulated other comprehensive gain 56 163
Accumulated deficit (773,198) (674,794)
Total stockholders' equity 233,253 319,263
Total liabilities and stockholders' equity 271,866 342,363
Preferred stock    
Stockholders' equity:    
Preferred stock
Series X redeemable convertible preferred stock    
Stockholders' equity:    
Preferred stock $ 95,324 $ 95,324